MX2009013197A - Derivados terapeuticos de pirazolonaftiridina. - Google Patents

Derivados terapeuticos de pirazolonaftiridina.

Info

Publication number
MX2009013197A
MX2009013197A MX2009013197A MX2009013197A MX2009013197A MX 2009013197 A MX2009013197 A MX 2009013197A MX 2009013197 A MX2009013197 A MX 2009013197A MX 2009013197 A MX2009013197 A MX 2009013197A MX 2009013197 A MX2009013197 A MX 2009013197A
Authority
MX
Mexico
Prior art keywords
gabaa
formula
therapeutic
animal
compound
Prior art date
Application number
MX2009013197A
Other languages
English (en)
Spanish (es)
Inventor
Jan W F Wasley
Alan P Kaplan
Varsha Gupta
Original Assignee
Helicon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helicon Therapeutics Inc filed Critical Helicon Therapeutics Inc
Publication of MX2009013197A publication Critical patent/MX2009013197A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2009013197A 2007-06-08 2008-06-06 Derivados terapeuticos de pirazolonaftiridina. MX2009013197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94300007P 2007-06-08 2007-06-08
PCT/US2008/066211 WO2008154447A1 (en) 2007-06-08 2008-06-06 Therapeutic pyrazolonaphthyridine derivatives

Publications (1)

Publication Number Publication Date
MX2009013197A true MX2009013197A (es) 2010-04-27

Family

ID=40130166

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013197A MX2009013197A (es) 2007-06-08 2008-06-06 Derivados terapeuticos de pirazolonaftiridina.

Country Status (12)

Country Link
US (2) US7858614B2 (OSRAM)
EP (1) EP2166853B1 (OSRAM)
JP (1) JP2010529145A (OSRAM)
KR (1) KR20100036306A (OSRAM)
CN (1) CN101754681A (OSRAM)
AU (1) AU2008261803A1 (OSRAM)
BR (1) BRPI0812369A2 (OSRAM)
CA (1) CA2689934A1 (OSRAM)
ES (1) ES2483728T3 (OSRAM)
IL (1) IL202287A0 (OSRAM)
MX (1) MX2009013197A (OSRAM)
WO (1) WO2008154447A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009013205A (es) * 2007-06-08 2010-04-09 Helicon Therapeutics Inc Derivados de pirazoloquinolina urea terapeuticos.
US9012470B2 (en) 2010-10-14 2015-04-21 Dart Neuroscience (Cayman) Ltd. Therapeutic 5,6,5-tricyclic analogs
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2017070481A1 (en) * 2015-10-23 2017-04-27 Harman International Industries, Incorporated Dual asymmetric compression driver
CN106810550A (zh) * 2017-01-10 2017-06-09 湖南华腾制药有限公司 一种萘啶衍生物的制备方法
CA3068350A1 (en) 2017-06-30 2019-01-03 Bayer Animal Health Gmbh New azaquinoline derivatives

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3204126A1 (de) 1982-02-06 1983-08-11 Bayer Ag, 5090 Leverkusen Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4479955A (en) * 1983-01-10 1984-10-30 Ciba-Geigy Corporation Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators
US4814450A (en) 1984-07-09 1989-03-21 Ciba-Geigy Corporation Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives
JPS61112075A (ja) 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
EP0214092A1 (en) 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
US4817450A (en) * 1987-11-30 1989-04-04 Spedco, Inc. Pressure/temperature test plug assembly
FR2695126B1 (fr) * 1992-08-27 1994-11-10 Sanofi Elf Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant.
US5334595A (en) 1992-10-23 1994-08-02 Sterling Winthrop Inc. Pyrazoloquinolones as anticancer agents
PT760819E (pt) * 1994-05-24 2000-11-30 Hoffmann La Roche Derivado dicarbonilicos triciclicos
GB9716347D0 (en) * 1997-08-01 1997-10-08 Merck Sharp & Dohme Therapeutic compounds
GB9716344D0 (en) * 1997-08-01 1997-10-08 Merck Sharp & Dohme Therapeutic compounds
GB9716345D0 (en) * 1997-08-01 1997-10-08 Merck Sharp & Dohme Therapeutic compounds
TWI271406B (en) * 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
GB0108475D0 (en) * 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
JP3896309B2 (ja) 2001-07-09 2007-03-22 ファイザー株式会社 プロテインキナーゼc阻害物質としてのピラゾロキノリノン誘導体
WO2004055014A1 (en) 2002-12-16 2004-07-01 Active Biotech Ab Tetracyclic immunomodulatory compounds
TW200508233A (en) 2003-05-29 2005-03-01 Millennium Pharm Inc Chk-1 inhibitors
CN1893943A (zh) * 2003-10-03 2007-01-10 3M创新有限公司 吡唑并吡啶和其类似物
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1937236A2 (en) * 2005-09-07 2008-07-02 Braincells, Inc. Modulation of neurogenesis by hdac inhibition
ATE544344T1 (de) * 2007-06-08 2012-02-15 Helicon Therapeutics Inc Therapeutische pyrazolochinolinderivate

Also Published As

Publication number Publication date
KR20100036306A (ko) 2010-04-07
US8497262B2 (en) 2013-07-30
US20090005365A1 (en) 2009-01-01
CA2689934A1 (en) 2008-12-18
EP2166853B1 (en) 2014-05-28
AU2008261803A1 (en) 2008-12-18
US7858614B2 (en) 2010-12-28
WO2008154447A1 (en) 2008-12-18
BRPI0812369A2 (pt) 2016-08-09
US20110065692A1 (en) 2011-03-17
HK1142774A1 (en) 2010-12-17
ES2483728T3 (es) 2014-08-07
EP2166853A4 (en) 2011-04-06
JP2010529145A (ja) 2010-08-26
IL202287A0 (en) 2010-06-16
EP2166853A1 (en) 2010-03-31
CN101754681A (zh) 2010-06-23

Similar Documents

Publication Publication Date Title
EA200900203A1 (ru) Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
MY149855A (en) Benzimidazole derivatives and their use for modulating the gaba? receptor complex
EA200802213A1 (ru) Способы лечения заболеваний крови
UA107783C2 (en) Isoindoline compounds for use in treating cancer
MX2010003949A (es) N-fenil-bipirrolidina carboxamidas sustituidas y uso terapeutico de las mismas.
MX2009013205A (es) Derivados de pirazoloquinolina urea terapeuticos.
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
MX2010003948A (es) N-fenil-birrolidin ureas sustituidas y uso terapeutico de las mismas.
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2010004003A (es) N-fenil-pirrolidinilmetlipirrolidin amidas sustituidas y uso terapeutico de las mismas.
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
MX2009013202A (es) Derivados terapeuticos de pirazoloquinolina.
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
DK1758860T3 (da) Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande
MX2009013197A (es) Derivados terapeuticos de pirazolonaftiridina.
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
ATE466841T1 (de) 1-phenethylpiperidinderivate und ihre verwendung als opioidrezeptor-liganden
MXPA06000701A (es) Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme
IL189974A0 (en) Benzimidazole derivatives and their use for modulating the gabaa receptor complex
UA103468C2 (ru) Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3

Legal Events

Date Code Title Description
FG Grant or registration